COMPARATIVE EFFECTIVENESS OF ORAL JANUS KINASE INHIBITORS VERSUS VEDOLIZUMAB IN ULCERATIVE COLITIS AFTER ANTI-TNF THERAPY FAILURE: A SYSTEMATIC REVIEW AND META-ANALYSIS

被引：0
|
作者：
Akhras, Aya
Abu-Rumaileh, Mohammed
Abbarh, Shahem
Sawaf, Bisher
Albandak, Maram
Rabeeah, Sana
Hallak, Yusuf O.
Alhayek, Mohammad
Alastal, Yaseen
Dahhan, Wael
机构：
来源：
INFLAMMATORY BOWEL DISEASES | 2025年 / 31卷
关键词：
D O I：
10.1093/ibd/izae282.018
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
izae282.01
引用
收藏
页码：S8 / S8
页数：1
相关论文
共 50 条
  • [21] Infliximab therapy in ulcerative colitis: Systematic review and meta-analysis
    Gisbert, J.
    Gonzalez-Lama, Y.
    Mate, J.
    INFLAMMATORY BOWEL DISEASES, 2007, 13 (05) : 662 - 662
  • [22] Vedolizumab as the first line of biologic therapy for ulcerative colitis and Crohn's disease - a systematic review with meta-analysis
    Attauabi, M.
    Madsen, G. R.
    Bendtsen, F.
    Seidelin, J. B.
    Burisch, J.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I483 - I484
  • [23] Effectiveness and Safety of Tofacitinib for Ulcerative Colitis Systematic Review and Meta-analysis
    Taneja, Vikas
    El-Dallal, Mohammed
    Haq, Zadid
    Tripathi, Kartikeya
    Systrom, Hannah K.
    Wang, Linda F.
    Said, Hyder
    Bain, Paul A.
    Zhou, Youlian
    Feuerstein, Joseph D.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2022, 56 (10) : E323 - E333
  • [24] Effectiveness of adalimumab in severe ulcerative colitis: A systematic review and a meta-analysis
    Azadbakht, Saleh
    Seighali, Masomeh
    Azadbakht, Salehe
    Azadbakht, Morteza
    HEALTH SCIENCE REPORTS, 2024, 7 (07)
  • [25] Vedolizumab as the first line of biologic therapy for ulcerative colitis and Crohn's disease - a systematic review with meta-analysis
    Attauabi, M.
    Madsen, G. R.
    Bendtsen, F.
    Seidelin, J. B.
    Burisch, J.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I483 - I484
  • [26] Janus Kinase Inhibitors for Alopecia Areata A Systematic Review and Meta-Analysis
    Liu, Ming
    Gao, Ya
    Yuan, Yuan
    Yang, Kelu
    Shen, Caiyi
    Wang, Jiancheng
    Tian, Jinhui
    JAMA NETWORK OPEN, 2023, 6 (06)
  • [27] Vedolizumab as the first line of biologic therapy for ulcerative colitis and Crohn's disease - a systematic review with meta-analysis
    Attauabi, Mohamed
    Madsen, Gorm Roager
    Bendtsen, Flemming
    Seidelin, Jakob Benedict
    Burisch, Johan
    DIGESTIVE AND LIVER DISEASE, 2022, 54 (09) : 1168 - 1178
  • [28] Changes in Anthropometric Parameters After Anti-TNFα Therapy in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
    Faizan Mazhar
    Vera Battini
    Marco Pozzi
    Elena Invernizzi
    Giulia Mosini
    Michele Gringeri
    Annalisa Capuano
    Cristina Scavone
    Sonia Radice
    Emilio Clementi
    Carla Carnovale
    BioDrugs, 2020, 34 : 649 - 668
  • [29] REAL-WORLD MULTICENTER COMPARISON OF EFFECTIVENESS BETWEEN TOFACITINIB AND VEDOLIZUMAB IN PATIENTS WITH ULCERATIVE COLITIS AFTER FAILURE TO AT LEAST ONE ANTI-TNF AGENT
    Buisson, Anthony
    Nachury, Maria
    Fumery, Mathurin
    Guilmoteau, Thomas
    Leclerc, Eloise
    Altwegg, Romain
    Serrero, Melanie
    Mathieu, Nicolas
    Treton, Xavier
    Vuitton, Lucine
    Pereira, Bruno
    Amiot, Aurelien
    Bouguen, Guillaume
    GASTROENTEROLOGY, 2022, 162 (07) : S604 - S604
  • [30] Comparative Efficacy of Janus Kinase Inhibitors and TNF Inhibitors in Ankylosing Spondylitis: A Network Meta-Analysis
    Castro, Adela
    Diaz, Jesus
    Quiceno, Guillermo
    Cush, John
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
12345